SABSW
Financials
- Market Capitalization 275.2707 M
- Employee 86
- Founded 2014
- CEO N/A
- Website www.sab.bio
- Headquarter Delaware, United States
- FIGI BBG00YHY0G24
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 6959 |  XOMAP XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock | 24.97 USD | 0.00% | +0.16% | -2.12% | -4.00% | 503.77 M USD | ||
| 6996 |  RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0029 USD | -3.33% | 0.00% | -42.00% | -92.54% | 396.37 M USD | ||
| 7165 |  SRZNW Surrozen, Inc. - Warrant | 0.0128 USD | 0.00% | +33.33% | -33.33% | -30.81% | 254.15 M USD | ||
| 7273 |  HUMAW Humacyte, Inc. - Warrant | 0.0091 USD | +19.74% | -9.00% | -61.44% | -98.11% | 157.63 M USD |
Frequently asked questions about SAB Biotherapeutics, Inc. - Warrant
What is the SAB Biotherapeutics, Inc. - Warrant stock price today?
The current price of SAB Biotherapeutics, Inc. - Warrant (SABSW) is 0.015. Over the past 24 hours, the stock has changed by +20.00%. Follow the SABSW chart for real-time price dynamics.
What is the stock ticker of SAB Biotherapeutics, Inc. - Warrant?
SAB Biotherapeutics, Inc. - Warrant trades under the ticker SABSW. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is SAB Biotherapeutics, Inc. - Warrant stock going up?
SABSW has changed by -37.50% over the last week, +17.19% over the last month, and -70.47% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was SAB Biotherapeutics, Inc. - Warrant net income for the last quarter?
SAB Biotherapeutics, Inc. - Warrant reported net income of -18.87 M for the last quarter. The previous quarter showed -16.86 M, which means net income changed by -11.91%.
How many employees does SAB Biotherapeutics, Inc. - Warrant have?
As of the latest available data, SAB Biotherapeutics, Inc. - Warrant has 86 employees. Workforce size can provide additional context about the company's scale and operations.
What is SAB Biotherapeutics, Inc. - Warrant EBITDA?
SAB Biotherapeutics, Inc. - Warrant EBITDA is -19.21 M, and its EBITDA margin is -37.06 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy SAB Biotherapeutics, Inc. - Warrant stock?
You can buy SAB Biotherapeutics, Inc. - Warrant (SABSW) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in SAB Biotherapeutics, Inc. - Warrant stock?
Investing in SAB Biotherapeutics, Inc. - Warrant requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SABSW chart and related analysis on metatrader.com as part of your research.